Smilesyou are right the FDA application slated for 2012 in terms of the people who want to flip stocks is a long way away. This is why Bob, Ken and Rod are stepping up to the mike. They know this drug is worth a lot more than the market is valuing it at and they want the media to pick up on the fact that. This company may be another ImClone a company bought out for several billion by Eli Lilly because they had a single cancer drug, Erbitux. This peptide that Pharmagap is developing can taget different cancers as shown by testing both the bladder and ovarian strands. Taking both of these to trials will be very important. Personally I believe that Ken will see them through to a successful conclusion.
It took 20 years to get Erbitux approved and Carl Icahn was controlling share holder.